GNA Biosolutions

Needs Review

GNA Biosolutions receives special approval for rapid corona test

The Munich-based biotechnology company GNA Biosolutions has developed Bavaria's first PCR-based rapid coronavirus test. Thanks to special approval from the Federal Institute for…

M4 Award Elab

Needs Review

GNA Biosolutions is working on a rapid corona test

The Munich-based biotechnology company GNA Biosolutions is working on a coronavirus test that aims to deliver a conclusive result in 15 minutes. The company…

GNA Biosolutions

Deals

Molecular diagnostics startup GNA Biosolutions closes Series C financing round

Molecular diagnostics startup GNA Biosolutions has closed a $13.5 million Series C financing round. The company was able to attract new investors such as Greybird…

GNA Biosolutions

Needs Review

GNA Biosolutions wins “Disruptive Technology Award”

GNA Biosolutions GmbH (GNA) won the Disruptive Technology Award at the 70th Conference of the American Association of Clinical Chemistry…